Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/07/2007CN100347225C Process for preparing biologically degradable reverse temperature sensitive material
11/07/2007CN100347196C Ganodema tsugae-proteoglycan and its preparing method and use
11/07/2007CN100347186C Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
11/07/2007CN100347185C Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
11/07/2007CN100347184C Bicyclic carbohydrate compounds useful in the treatment of infections caused by flaviviridae sp., such as hepatitis c and bovine viral diarrhea viruses
11/07/2007CN100347176C Novel dithiolopyrrolones with therapeutic activity
11/07/2007CN100347174C Heterocyclic hepyramine derivative, its preparation and use thereof
11/07/2007CN100347173C Pyrazoloquinolines with immunomodulating activity
11/07/2007CN100347172C Azaindole-derivatives as factor Xa inhibitors
11/07/2007CN100347171C Pyridine compounds and their prepn and application as Dopamine D4 receptor agonist
11/07/2007CN100347170C Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
11/07/2007CN100347169C 喹唑啉衍生物 Quinazoline derivatives
11/07/2007CN100347168C Indazolamides with analgesic activity
11/07/2007CN100347167C Process for producing substituted 2-(2-pyridylmethye)sulfinye-1H-benzinmidazoles
11/07/2007CN100347164C Benzofuryl derivatives and their use
11/07/2007CN100347163C Cyclohexenone analog bicyclo (condensed ring) compound and its preparation method and uses
11/07/2007CN100347162C N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative
11/07/2007CN100347161C Pna单体和前体 Pna monomers and precursors
11/07/2007CN100347158C Bicyclic compound
11/07/2007CN100347153C Amidoacetonitrile compounds and their use as pesticides
11/07/2007CN100347152C Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
11/07/2007CN100347151C Novel aminobenzoephenones
11/07/2007CN100346850C Medicine coating rack
11/07/2007CN100346834C Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy
11/07/2007CN100346833C Formulation for inwardly transferring nucleic acids into eucaryotic cells
11/07/2007CN100346832C Pharmaceutical dosage form for mucosal delivery
11/07/2007CN100346831C Combination of a PDE inhibitor and a leukotriene receptor antagonist
11/07/2007CN100346830C Medicinal composition for treating B cell lymph tumour
11/07/2007CN100346829C Adjuvant compsn comprising immunostimulatory oligonucleotide and tocol
11/07/2007CN100346805C Application of shinyleaf yellowhorn fruit shell in preparing cerbral function improving food and medicine
11/07/2007CN100346797C Compound injection from ice tablet and ginkgo leaf extract and its making method thereof
11/07/2007CN100346794C Method of reducing toxicity of anticancer agents
11/07/2007CN100346793C Use of cepharanthine for preparing HSV-II drug
11/07/2007CN100346792C Benzothiazole derivatives as adenosine receptor ligands
11/07/2007CN100346791C Controlled and released preparation of kurarinone detained in stomach
11/07/2007CN100346790C Application of (+) North America coptisine
11/07/2007CN100346789C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury
11/07/2007CN100346787C Composite medicine containing flucloxacillin magnesium and amoxicillin sodium
11/07/2007CN100346786C Substituted benzimidazole compounds and their use for the treatment of cancer
11/07/2007CN100346785C Preparation of selective epoxide hydrolase II inhibitor
11/07/2007CN100346784C Pharmaceutical formulations of antineoplastic agents,in particular temozolomide, processes of making and using the same
11/07/2007CN100346783C Sustained released malotilate preparation for hepa titis and cirrhosis
11/07/2007CN100346782C Vitamin C composition containing amino acids
11/07/2007CN100346781C Use of okadaic acid in preparation of medicine for resisting glaucoma operation scar
11/07/2007CN100346780C Compound preparation for prevention and treatment adiposis and its prepn. method
11/07/2007CN100346779C Liquid pharmaceutical composition
11/07/2007CN100346778C Nimesulide sustained release medicinal composition
11/07/2007CN100346777C New synergistic combination comprising roflumilast and formoterol
11/07/2007CN100346776C Remedies
11/07/2007CN100346774C Treatment agent
11/07/2007CN100346773C Liposome preparation of propionic acid clobetasol
11/07/2007CN100346772C Devices for delivery of drugs having antiprogestinic properties
11/07/2007CN100346725C Stable and bioavailable iron fortified beverages
11/06/2007USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007US7291746 Preparing levetiracetam by deaminomethylation of the pure enantiomer intermediate: N-(dialkylamino- (or -pyrrolidinyl-, piperidinyl-, morpholinyl-, piperazinyl- or alkylpiperazinyl-)methyl)2-pyrrolidonylbutyramide or its acid addition salt
11/06/2007US7291744 N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
11/06/2007US7291740 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Mesylate salt
11/06/2007US7291737 Cocaine receptor binding ligands
11/06/2007US7291736 3-[2-(dimethylamino)ethyl]-1-[(3-fluorophenyl)sulfonyl]-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one; anxiety disorder or a cognitive disorder; central nervous system disorders; psychological disorders; neurodegenerative disorder; attention deficit disorder; obsessive compulsive disorder; Alzheimer's
11/06/2007US7291733 pyrido[3',2':4,5]thieno[3,2-d]-pyrimidines (or triazines or pyridines); inhibitors of the kinase activity of the I kappa B kinase (IKK) complex; autoimmune diseases, inflammatory diseases and cancer; lupus, rheumatoid arthritis, breast canser
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007US7291731 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents
11/06/2007US7291728 Spirolactams and their synthesis
11/06/2007US7291725 Sos1 inhibitors
11/06/2007US7291720 Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections
11/06/2007US7291713 For modifying polypeptides
11/06/2007US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension
11/06/2007US7291673 Polymeric biomaterials formed by nucleophilic addition reactions to conjugated unsaturated groups
11/06/2007US7291650 Breast cancer ; therapy containing plant extracts
11/06/2007US7291649 Forming germicidal aromatic dialdehydes with acetals
11/06/2007US7291648 3,3-diphenylpropylamines useful in therapy
11/06/2007US7291647 For therapy of inflammation, for inhibition of the release of TNF alpha, nitric oxide
11/06/2007US7291646 Central nervous system disorders; anxiolytic agents; antidepressants; attention deficit disorders; Alzheimer's disease; Parkinson's disease; antiepileptic agents; schizophrenia; drug abruse; eating disorders; analgesics ; sexual disorders
11/06/2007US7291645 Phenylalanine derivatives as alpha 4 integrin inhibitors
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291643 E.g., N-[4-(5-cyano-1-methyl-1H-pyrrol-2-yl)phenyl]propane-1-sulfonamide and tert-butyl 2-cyano-5-{4-{(ethylsulfonyl)amino]phenyl}-1H-pyrrole-1-carboxylate; useful for contraception and hormone replacement therapy
11/06/2007US7291642 Bradykinin-B1 antagonists, process for their preparation and their use as medicaments
11/06/2007US7291641 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
11/06/2007US7291640 Substituted triazole derivatives as oxytocin antagonists
11/06/2007US7291639 Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/06/2007US7291638 3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291636 E.g., Methyl 2-[2-[2-(3,5-difluorophenyl)acetyl-amino]propanoylamino]-5-propylthiazole-4-carboxylate; beta -amyloid peptide inhibitors; used to treat senile dementia, Alzheimer's disease, Down's syndrome, Parkinson's disease, amyloid angiopathy and/or cerebrovascular disorders
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/06/2007US7291634 N-substituted-benzyl-N-(hydroxyaminocarbonylmethyl)cycloalkyl(alk)oxybenzenesulfonamides, e.g., 2-[(cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-1-yl-benzyl)-amino]-N-hydroxy-acetamide; treating diseases mediated by matrix-degrading metalloproteinases, in particular hyperproliferative diseases
11/06/2007US7291633 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy
11/06/2007US7291632 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists
11/06/2007US7291631 aminoalkylpyridines, e.g., N-(1H-benzimidazol-2-ylmethyl)-N-(3-methylpyridin-2-ylmethyl)-butane-1,4-diamine; treating HIV infection and inflammatory conditions such as rheumatoid arthritis; elevating progenitor and stem cell counts, as well as white blood cell counts
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
11/06/2007US7291629 Neurotrophin antagonist compositions
11/06/2007US7291628 Treatment of cocaine abuse using N-substituted derivatives of morphinan
11/06/2007US7291627 E.g., 8-chloro-3,11-dimethyl-5,6-dihydroimidazo[5,1-a]- beta -carboline methane sulfonate; used for reducing alertness and/or for accelerating the onset of sleep
11/06/2007US7291626 Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
11/06/2007US7291625 Administering a combination of nicotinic acid or nicotinamide and riboflavin to treat urticaria, asthma, allergic rhinitis, and allergic oculorhinitis
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291623 Compounds that interact with kinases
11/06/2007US7291622 Administering a 4-Amino-2-[1-(o-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinylcarbamate derivative, optionally mixed with an organic nitrate or NO donor or a cGMP inhibitor for treating sexual dysfunction
11/06/2007US7291621 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma; e.g., 2-Methoxynaphthalene-1-carboxylic acid benzyl-indan-2-yl-amide
11/06/2007US7291620 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
11/06/2007US7291619 Melanocortin receptor agonists
1 ... 3516 3517 3518 3519 3520 3521 3522 3523 3524 3525 3526 3527 3528 3529 3530 3531 3532 3533 3534 3535 3536 ... 7860